The goal of gene therapy is to permanently cure hereditary diseases. One of the most promising technologies for this is the ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $67.21, marking a +1.04% move from the previous day. The stock exceeded the S&P 500, which registered a gain of 0.58% for the day ...

Also! In honor of World CRISPR Day (yesterday, but close enough), we have a very special 50% discount rate if you sign up for ...

BRENTFORD, ENGLAND, UNITED KINGDOM, October 14, 2025 / EINPresswire.com / -- The global CRISPR gene-editing market is expected to witness significant growth, projected to rise from a valuation of US$ ...

India's biotech boom, challenges, and strategic priorities for future growth in healthcare and life sciences discussed by ...

At the STAT Summit in Boston yesterday, Kyle and Nicole Muldoon shared the story of how their son, Baby KJ — once facing ...

Discover the hidden potential of medicinal plant stem cells! These powerful cells offer sustainable solutions for everything from anti-aging skincare ...

Depending on the setting, the ability of a crucial bacterium in biotechnology—Agrobacterium tumefaciens—to transfer its DNA ...

Despite setbacks and funding cuts — and a quieting of the hype blaring its arrival — multiple CRISPR-based trials are ...

CRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...

We have the tech to make designer babies but we are not ready for it yet. Read more at straitstimes.com. Read more at straitstimes.com.